ASCO Genitourinary Cancers Symposium 2025

ASCO Genitourinary Cancers Symposium 2025

Oncology

Overview

Program The 2025 ASCO Genitourinary Cancers Symposium will provide expert, multidisciplinary perspectives on the latest clinical and scientific advances in the field. View the official Meeting Announcement for a message from the Chair, Program Highlights, Featured Sessions information, and how to register.

Program At A Glance Thursday, February 13, 20257:00 AM- 8:00 AMComplimentary Continental Breakfast7:00 AM- 6:45 AMExhibits Open8:00 AM- 9:40 AMOral Abstract Session A: Prostate Cancer Kosj Yamoah, MD, Ph D—Chair H. Lee Moffitt Cancer Center and Research Institute Channing Judith Paller, MD—Chair The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Peter Hoskin, MD, FRCP, FRCR Welcome of the Day ABSTRACT 308: Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.

First Author: Shuang Zhao, MDABSTRACT 309: Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs).

Course Details

• Price: $240.00
• Access Type: Lifetime
• Delivery Method: Google Drive Link, Offline
• Content Format: Mixed

What's Included

• Video lectures and recordings

Target Audience

Specialists

Key Features

• Expert-led instruction and content
• Comprehensive coverage of topic area
• Flexible learning schedule
• Lifetime access to all materials